From finding love and securing jobs to pursuing their dreams, Nigerians with Down’s syndrome are defying prejudice and challenging stereotypes to live fulfilling lives. Despite stigma and limited ...
If your back and knees hurt and there are random pimples popping up where they haven't before... You should read this post!
Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...
Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% ...